Navigation Links
Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
Date:6/26/2008

ATLANTA, June 26 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim month three safety and efficacy results from the first human pharmacokinetic (PK) study of Medidur(TM) FA, which Alimera Sciences intends to market under the tradename Iluvien(TM), if approved by the U.S. Food and Drug Administration.

This 36-month, open-label Phase 2 study, running concurrently with the pivotal Phase 3 FAME(TM) Study (Fluocinolone Acetonide in Diabetic Macular Edema), is designed primarily to assess systemic exposure of the corticosteroid, fluocinolone acetonide (FA), after administration of Iluvien in diabetic macular edema (DME) patients. Secondarily, the study is designed to provide information on the safety and efficacy of Iluvien in a DME population. A total of 37 subjects were enrolled in this trial, 20 patients on the low dose (an approximate 0.23 microgram per day dose) of Iluvien, and 17 patients on the high dose (an approximate 0.45 microgram per day dose) with the same inclusion/exclusion criteria as the ongoing Phase 3 FAME Study.

Iluvien is an intravitreal insert being developed for the treatment of DME. DME is a disease of the retina, which affects individuals with diabetes and can lead to severe vision loss and blindness. Each Iluvien insert is designed to provide a sustained therapeutic effect, up to 24 months for the low dose and up to 36 months for the high dose. Iluvien is inserted into the patient's eye with a 25-gauge needle, which allows for a self-sealing wound. This insertion is very similar to an intravitreal injection, a procedure commonly employed by retinal specialists.

This three-month interim readout from the PK Study indicated 20 percent of the low dose patients and 18 percent of the high dose patients showed an improvement in best-corrected visual acuity
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and ... results from a Category 3 human abuse ... extended-release, oral oxycodone product candidate in late-stage ... severe enough to require daily, around-the-clock opioid ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging Market ... Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, Canisters, ... By Geographical Region ( North America , ... Latin America , Middle East ... Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, Restraints, ...
(Date:6/29/2015)... PARK, Calif. , June 29, 2015  Nevro ... company that is providing innovative evidence-based solutions for the ... Earnhardt , President and Chief Executive Officer of Intersect ... its Board of Directors, effective June 28, 2015. ... Earnhardt has successfully led Intersect ENT, a company ...
Breaking Medicine Technology:Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... DIEGO, April 19, 2011 Sangart, Inc., today announced that ... funding from existing investors, led by Leucadia National Corporation. The ... company since its inception in 1998 to more than $230 ... could provide up to an additional $50 million in future ...
... Ohio woman suffered bone deterioration and broken bones because ... reflux drug Nexium,  The Gibson Law Firm alleges ... Filed in the U.S. District Court in ... Ohio, suffered serious bone deterioration after taking Nexium ...
Cached Medicine Technology:Sangart Announces Closing of $50 Million Series G Financing 2AstraZeneca Sued Over Alleged Nexium Injuries, According to The Gibson Law Firm 2
(Date:6/30/2015)... ... June 30, 2015 , ... India Network Foundation ... Inc. for its visitor health insurance plans that provides coverage for visitors to the ... nationwide to enable visitors to obtain services from most experienced health care professional close ...
(Date:6/30/2015)... ... , ... Due to today’s housing market, many people cannot afford to “down size” as they ... adjustments as to how to carry laundry or groceries from one level of their home ... or first floor of the home, and the bedrooms are located on another floor. ...
(Date:6/30/2015)... ... 2015 , ... Amerec, a division of TyloHelo Inc, is pleased to announce ... now approved by the Interior Design Continuing Education Council for 1 credit hour. ... explanation of what sauna, steam, and far-infrared saunas are, where they are frequently installed, ...
(Date:6/30/2015)... ... June 30, 2015 , ... It has become fairly common to purchase fresh ... discard the stalks before cooking. Throwing out radish greens, beet leaves and chard stalks ... delicious. It just takes a little knowledge and practice to use them. Josie's ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... the U.S. after a 5-day tour in India. During her stay, she ... with Trivedi Master Wellness™ and Transformational Leader/Internationally Beloved Spiritual Master Mahendra ...
Breaking Medicine News(10 mins):Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2Health News:Amerec’s Steam and Sauna Continuing Education Course Now Approved for Interior Design Credit 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3
... March 14 MedQuist Inc.,(Pink Sheets: MEDQ.PK). On ... sheet with the individual named plaintiffs and certain,other ... the,South Broward customer class action. As previously announced, ... filed against the company and certain,present and former ...
... the symptoms, the higher the chances of trouble, study ... have the most severe menopausal symptoms may also be at ... , Dutch researchers surveyed 5,648 women, aged 46 to 57, ... information such as their cholesterol and blood pressure. , Night ...
... Minn., March 14 Researchers at,Mayo Clinic suggest ... persons over 80 years old should be "revisited." ... the American Journal of,Geriatric Cardiology., After analyzing ... older, the,researchers discovered that the average cutoffs (beginning ...
... Clinic suggest that the established normal ranges for evaluating ... revisited. The recommendation comes in a study published today ... analyzing readings from more than 700 patients 80 or ... and end points) for measuring all three ECG intervals ...
... (NYSE: EW ), a world leader in products ... participate in the,Citi 5th Annual Small and Mid-Cap Conference ... March 19, 2008., Donald E. Bobo, Edwards Lifesciences, ... to conference attendees at 1:05 p.m.,PT. A live webcast ...
... American Heart Association meeting report, COLORADO SPRINGS, ... appears to induce markers for heart disease as ... American Heart Association,s,48th Annual Conference on Cardiovascular Disease ... that many forms of cardiovascular disease in,adults are ...
Cached Medicine News:Health News:MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation 2Health News:MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation 3Health News:Severe Menopause Symptoms Raise Heart Risks 2Health News:Severe Menopause Symptoms Raise Heart Risks 3Health News:Mayo Researchers Say ECG Standards Should Be Revised for Elderly 2Health News:Mayo researchers say ECG standards should be revised for elderly 2Health News:Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference 2Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 2Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 3Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: